Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
HONYA Medical General Information
HONYA Medical is developing advanced stem cell therapies targeting cardiovascular and degenerative conditions. Their lead programs are in early clinical stages, with at least one program in Phase 1/2 for acute myocardial infarction and another in Phase 1 for coronary artery disease. The company leverages proprietary technologies to create personalized, ethically sourced stem cell products manufactured under GTP/GMP standards. No published late-stage or commercial results as of the latest update.
Contact Information
Drug Pipeline
MiSaver
Clinical trialKey Partnerships
HONYA Medical Funding
No funding data available
To view HONYA Medical's complete valuation and funding history, request access »